What a TSPO PET scan actually detects
A PET scan can map where a radioactive tracer accumulates in the brain. Some tracers are designed to bind to TSPO, a protein found in the outer membranes of mitochondria—the energy-producing structures inside cells. TSPO levels can rise in brain immune cells, including microglia, when they change their activity during injury or inflammation.
The tracer does not seek out a protein released by angry cells. After injection, it travels through the bloodstream and binds to available TSPO; as the radioactive atoms decay, the scanner detects signals that help reconstruct a map of tracer distribution. The resulting image is a color-coded rendering of that signal, not a photograph of individual cells or a glowing trail of inflammation.
Why the signal is an indirect clue
Microglia are not the only brain cells that can contain TSPO. Astrocytes and cells associated with blood vessels may contribute to the signal, and a scan cannot by itself reveal which cells produced it or exactly what they are doing. Researchers therefore treat TSPO PET as an indirect measure of a biological process, not a direct count of activated microglia.
Interpreting the image also takes care: tracer binding can vary with a person’s genetic makeup, and the signal may reflect several processes besides inflammation. A bright area is not a stand-alone diagnosis or proof that a particular condition has a single cause.
What the scan can add
In research, PET can help investigators compare brain activity patterns across groups or track how a signal changes over time. That makes it a useful way to test whether immune-related processes are involved in a condition—but the image is one piece of evidence, to be interpreted alongside symptoms and other findings. Its value lies not in making inflammation visible like a flame, but in giving researchers a measurable clue about where to investigate further.
